WestEnd Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.88K | Buy |
|
|||||
|
2025
Q1 | $5.27K | Buy |
|
|||||
|
2024
Q4 | $1.48K | Buy |
|
|||||
|
2024
Q3 | $1.17K | Sell |
|
|||||
|
2024
Q2 | $1.1K | Sell |
|
|||||
|
2024
Q1 | $1.47K | Buy |
|
|||||
|
2023
Q4 | $1.54K | Buy |
|
|||||
|
2023
Q3 | $1.27K | Buy |
|
|||||
|
2023
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.29K | Sell |
|
|||||
|
2022
Q3 | $1K | Buy |
|
|||||
|
2022
Q2 | $927 | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $726 | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $29.5M | Sell |
|
|||||
|
2019
Q3 | $30.5M | Sell |
|
|||||
|
2019
Q2 | $34.2M | Sell |
|
|||||
|
2019
Q1 | $34.8M | Buy |
|
|||||
|
2018
Q4 | $27.9M | Sell |
|
|||||
|
2018
Q3 | $40.1M | Sell |
|
|||||
|
2018
Q2 | $37.7M | Sell |
|
|||||
|
2018
Q1 | $41.4M | Buy |
|
|||||
|
2017
Q4 | $39.1M | Sell |
|
|||||
|
2017
Q3 | $56.8M | Sell |
|
|||||
|
2017
Q2 | $53.5M | Sell |
|
|||||
|
2017
Q1 | $55.4M | Buy |
|
|||||
|
2016
Q4 | $52.6M | Sell |
|
|||||
|
2016
Q3 | $68.3M | Sell |
|
|||||
|
2016
Q2 | $93.3M | Buy |
|
|||||
|
2016
Q1 | $99.4M | Buy |
|
|||||
|
2015
Q4 | $97M | Buy |
|
|||||
|
2015
Q3 | $92.1M | Sell |
|
|||||
|
2015
Q2 | $122M | Sell |
|
|||||
|
2015
Q1 | $107M | Buy |
|
|||||
|
2014
Q4 | $94.1M | Buy |
|
|||||
|
2014
Q3 | $97.2M | Sell |
|
|||||
|
2014
Q2 | $103M | Sell |
|
|||||
|
2014
Q1 | $90.7M | Buy |
|
|||||
|
2013
Q4 | $69.8M | Sell |
|
|||||
|
2013
Q3 | $85.9M | Sell |
|
|||||
|
2013
Q2 | $76.9M | Buy |
|